Zomedica Corp.

AMEX: ZOM · Real-Time Price · USD
0.10
0.00 (2.56%)
At close: Mar 04, 2025, 9:50 AM

Zomedica Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue
26.73M 26.08M 25.97M 25.19M 24.01M 22.43M 20.66M 18.93M 16.85M 12.1M 7.87M 4.13M 52.33K 29.82K 14.12K n/a n/a n/a n/a
Cost of Revenue
11.96M 12.01M 10.24M 9.74M 7.47M 6.7M 5.93M 5.28M 4.43M 3.24M 2.06M 1.08M 59.43K 41.53K 5.66K n/a n/a n/a n/a
Gross Profit
14.77M 14.07M 15.73M 15.45M 16.54M 15.74M 14.73M 13.65M 12.42M 8.86M 5.81M 3.05M -7.1K -11.72K 8.47K n/a n/a n/a n/a
Operating Income
-38.26M -36.77M -34.47M -31.59M -25.34M -25.98M -25.12M -21.92M -22.54M -22.36M -21.81M -21.37M -19.74M -18.33M -18.3M -16.76M -15.49M -13.34M -10.43M
Interest Income
4.26M 4.72M 5.14M 5.46M 5.61M 5.19M 4.01M 2.7M 1.49M 574.19K 409.3K 357.45K 272.85K 199.78K 87.92K 32.78K 21.48K 247.00 n/a
Pretax Income
-62.07M -57.76M -39.01M -35.86M -17.77M -21.01M -21.34M -19.38M -21.15M -21.84M -20.89M -20.72M -19.27M -17.9M -18.5M -16.91M -15.6M -13.46M -10.56M
Net Income
-62.19M -55.99M -37.31M -34.53M -14.93M -19.44M -19.46M -17.01M -17.49M -18.85M -18.28M -18.38M -19.27M -17.9M -18.5M -16.91M -15.6M -13.46M -10.56M
Selling & General & Admin
44.8M 43.59M 43.6M 41.3M 38.46M 38.03M 36.7M 33M 32.5M 29.6M 26.04M 22.78M 17.8M 13.85M 10.08M 8.16M 6.85M 6.36M 6.22M
Research & Development
8.22M 7.24M 6.6M 5.74M 3.42M 3.69M 3.15M 2.58M 2.47M 1.62M 1.58M 1.64M 1.81M 4.22M 7.86M 8.08M 8.03M 6.29M 3.44M
Other Expenses
21K 2.22M 2.16M 2.08M 2.19M -5K -4K -4K 44.38K 49.98K 26.78K 27.78K -20.46K -19.09K 125.95K 131.45K 334K 529.76K 603.45K
Operating Expenses
53.02M 50.83M 50.2M 47.04M 41.88M 41.72M 39.85M 35.57M 34.97M 31.23M 27.62M 24.43M 19.73M 18.32M 18.31M 16.76M 15.49M 13.34M 10.43M
Interest Expense
n/a 64K 126K 176K 177K 1.13M 1.06M 1.12M 1.12M 110.46K 116.51K 9.51K 6.13K 6.13K 81.00 732.00 651.00 651.00 12.81K
Selling & Marketing Expenses
16.23M 15.67M 14.83M 14.14M 13.24M 13.64M 10.56M 7.15M 3.73M n/a n/a n/a 84.97K 144.53K 212.36K 261.91K 351.57K 457.85K 468.93K
Cost & Expenses
64.98M 62.84M 60.43M 56.78M 49.34M 48.42M 45.78M 40.85M 39.4M 34.47M 29.69M 25.51M 19.79M 18.36M 18.32M 16.76M 15.49M 13.34M 10.43M
Income Tax Expense
123K -1.77M -1.7M -1.33M -2.84M -1.57M -1.88M -2.37M -3.65M -2.96M -3.11M -2.62M -224.91K -254.54K 285.21K 187.53K 130.18K 128.75K 124.31K
Shares Outstanding (Basic)
979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.9M 979.9M 978.49M 978.49M 942.2M 890.25M 890.25M 550.54M 214.83M 118.34M
Shares Outstanding (Diluted)
979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.9M 979.9M 978.49M 978.49M 973.66M 890.25M 890.25M 550.54M 214.83M 118.34M
EPS (Basic)
-0.06 -0.06 -0.04 -0.04 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.04 -0.06 -0.08 -0.1 -0.09
EPS (Diluted)
-0.06 -0.06 -0.04 -0.04 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.04 -0.06 -0.08 -0.1 -0.09
EBITDA
-54.27M -50.32M -32.02M -29.39M -11.94M -15.68M -16.71M -15.34M -17.51M -19.32M -19.72M -20.09M -19.35M -17.91M -17.86M -16.38M -14.98M -12.77M -9.8M
EBIT
-62.07M -57.69M -38.88M -35.69M -16.33M -19.64M -20.03M -18.11M -21.15M -21.9M -21.58M -21.23M -19.78M -18.35M -18.33M -16.91M -15.59M -13.46M -10.54M
Depreciation & Amortization
7.81M 7.37M 6.87M 6.3M 5.66M 5.22M 4.58M 4.04M 3.63M 2.58M 1.85M 1.14M 431.04K 447.46K 469.77K 530.02K 614.04K 688.16K 761.85K